Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06284330
Status:
RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-02-01
Brief Title:
CHARGE Study CHoice ARchitecture Genetic tEsting
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Study Overview
Official Title:
CHARGE CHOICE ARCHITECTURE IN GENETIC TESTING
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CHARGE
Brief Summary:
CHARGE is a hybrid type I feasibility study to compare a choice architecture intervention for cascade genetic testing to usual care
Detailed Description:
CHARGE study contains two arms Arm 1 Usual care comprising of standard genetic counseling and education to probands regarding cascade testing and Arm 2 Direct mailing of a home genetic testing kit to probands at-risk relatives that can be returned directly to a commercial genetic testing laboratory including educational information on the importance and cost of cascade testing
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None